In vitro and in vivo responses to short-term recombinant human insulin- like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene

Clinical Endocrinology

Volumn 51, Issue 5, 1999, Pages 541-550

  De Lacerda, Luiz ^a   Carvalho, Julienne A R ^a   Stannard, Bethel ^b   Werner, Haim ^b   Boguszewski, Margaret C S ^a   Sandrini, Romolo ^a   Malozowski, Saul N ^c   LeRoith, Derek ^b   Underwood, Louis E ^d  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GROWTH HORMONE; MESSENGER RNA; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THYROTROPIN;

ARTICLE; CALCIUM URINE LEVEL; CASE REPORT; CHROMOSOME 15Q; FEMALE; GENE DELETION; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NITROGEN URINE LEVEL; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; SCHOOL CHILD; SKIN BIOPSY; SKIN FIBROBLAST; SOUTHERN BLOTTING; SUBCUTANEOUS DRUG ADMINISTRATION;

BLOTTING, SOUTHERN; CELLS, CULTURED; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; FIBROBLASTS; GENE DELETION; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS; RING CHROMOSOMES; RNA, MESSENGER;

EID: 0032724368     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00799.x     Document Type: Article

References (40)

1. Albertsson-Wikland, K., Rosberg, S. & Libre, E. (1989) Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. American Journal of Physiology. 257, 809814.
2. Baba, T., Kinoshita, E., Matsumoto, T., Yoshimoto, M., Tamura, T., Niikawa, N. & Tsuji, Y. (1992) A case of ring 15 chromosome syndrome with phenotype of Russell-Silver syndrome and deletion of the gene for the insulin-like growth factor-1 receptor. Acta Paediatrica Scandinavica, 383, 111.
3. Backeljauw, P.F., Underwood, L.E., The, G.H.I.S. & Collaborative Group (1996) Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - a clinical research center study. Journal of Clinical Endocrinology and Metabolism, 81, 3312-3317.
4. Baker, J., Liu, J.-P., Robertson, E.J. & Efstratiadis, A. (1993) Role of insulin-like factors in embryonic and postnatal growth. Cell, 75, 73-82.
5. Baxter, R.C. (1990) Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor binding protein complex. Journal of Clinical Endocrinology and Metabolism, 70, 1347-1353.
6. Beck, K.D., Powell-Braxton, L., Widmer, H.R., Valverde, J. & Hefti, F. (1995) IGF-I gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule striatal parvalbumin containing neurons. Neuron, 14, 717-730.
7. Bermann, M., Jaffe, C.A., Tsai, W., Dermott-Friberg, R. & Barkan, L. (1994) Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Journal of Clinical Investigation, 94, 138-145.
8. Butler, M.G., Fogo, A.B., Fuchs, D.A., Collins, F.S., Dev, V.G. & Phillips, J.A. III (1988) Brief clinical report and review: two patients with ring chromosome 15 syndrome. American Journal of Medical Genetics, 29, 149-154.
9. Camacho-Hubner, C., Busby, W.H., McCusker, R.H., Wright, G. & Clemmons, D.R. (1992) Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. Journal of Biological Chemistry, 267, 11949-11956.
10. Clemmons, D.R., Snyder, D.K. & Busby, W.H. (1991) Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. Journal of Clinical Endocrinology and Metabolism, 73, 727-733.
11. Copeland, K.C., Underwood, L.E. & Van Wyk, J.J. (1980) Induction of immunoreactive somatomedin C in human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. Journal of Clinical Endocrinology and Metabolism, 50, 690-697.
12. Cotterill, A.M., Camacho-Hubner, C., Molly, J.M.P. & Savage, M.O. (1993) The effect of recombinant human insulin-like growth faclor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome). Clinical Endocrinology, 39, 119-122.
13. Davenport, M.L., Svoboda, M.E., Koerber, K.L., Van Wyk, J.J., Clemmons, D.R. & Underwood, L.E. (1988) Plasma concentrations of insulin-like growth factor II (IGF-11) are not changed by short-term fasting and refeeding. Journal of Clinical Endocrinology and Metabolism, 67, 1231-1236.
14. D'Ercole, A.J., Ve, P., Calikoglu, A.S. & Gutierrez-Ospina, G. (1996) The role of the insulin-like growth factors in the central nervous system. Molecular Endocrinology, 13, 227-255.
15. Esposito, D.L., Blakesley, V.A., Koval, A.P., Scringeour, A.G. & LeRoith, D. (1997). Tyrosine residues in the C-terminal domain of the insulin-like growth factor I receptor mediate mitogenic and tumorigenic signals. Endocrinology, 138, 2979-2988.
16. Francke, U., Darras, B.T. & Foellmer, B.E. (1988) Loss of type 1 IGF receptor gene in patients with ring chromosome 15 is related to Russell-Silver like phenotype. In Proceedings of the 9th Annual David W Smith Workshop on Malformations and Morphogenesis. Oakland CA.
17. Greulich, W.W. & Pyle, S.I. (1959) Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford University Press, Palo Alto.
18. Han, V.K.M., Lund, P.K., Lee, D.C. & D'Ercole, A.J. (1988) Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characlerization, and tissue distribution. Journal of Clinical Endocrinology and Metabolism, 66, 422-429.
19. Heath-Monnig, E., Wohltmann, H.J., Mills-Dunlap, B. & Daughaday, W.H. (1987) Measurement of insulin-like growth factor 1 (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-I resistance. Journal of Clinical Endocrinology and Metabolism, 64, 501-507.
20. Hochberg, Z., Pollack, S. & Aviram, M. (1993) Resistance to insulin like growth factor-1 in Turner syndrome. In: Basic and Clinical Approach to Turner Syndrome. (eds. I. Hibi & K. Takano), pp. 233-237. Elsevier, Amsterdam.
21. Kato, H., Faria, T.N., Stannard, B., Roberts, C.T. & JrLeRoith, D. (1993) Role of tyrosine kinase activity in signal transductions by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-receptors and the action of an IGF-I mimetic antibody (aIR-3). Journal of Biological Chemistry, 268, 2655-2661.
22. Kaye, P.L., Bell, K.L., Beebe, L.F., Dunglison, G.F., Gardner, H.G. & Harvey, M.B. (1992) Insulin and insulin-like growth factors (IGFs) in preimplantation development. Reproduction Fertilization and Development. 4, 373-386.
23. Kupfer, S.R., Underwood, L.E., Baxter, R.C. & Clemmons, D.R. (1993) Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. Journal of Clinical Investigation, 91, 391-396.
24. Laron, Z., Klinger, B., Silbergeld, A., Lewin, B., Erster, B. & Gil-Ad, I. (1990) Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Ada Endocrinologica, 123, 378-382.
25. Laron, Z., Klinger, B., Jensen, L.T. & Erster, B. (1991) Biochemical and hormonal changes induced by one week administration of rIGF-I to patients with Laron type dwarfism. Clinical Endocrinology, 35, 145-150.
26. Liu, J.-P., Baker, J., Perkins, A.S., Robertson, E.J. & Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type IIGF receptor (IGF-Ir). Cell, 75, 59-72.
27. Lowe, W.L., Schaffner, A.I., Roberts, C.T. Jr & LeRoith, D. (1987) Developmental regulation of somatostatin gene expression in the brain is region specific. Molecular Endocrinology, 1, 181-187.
28. Merrian, G.R. & Wachter, K.W. (1982) Algorithms of the study of episodic hormone secretion. American Journal of Physiology, 243, 310-318.
29. Nilsson, K.O., Albertsson-Wikland, K., Alm, J., Aronson, S., Gustafsson, J., Hagenäs, L., Häger, A., Ivarsson, S.A., Karlberg, J., Kriström, B., Marcus, C., Moell, C., Ritzén, M., Tuvemo, T., Wattsgard, C., Westgren, U., Westphal, O. & Aman, J. (1996) Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. Journal of Clinical Endocrinology and Metabolism, 81, 635-640.
30. Roback, E.W., Barakat, A.J., Dev, V.G., Mbikay, M., Mhretien, M. & Butler, M.G. (1991) An infant with deletion of the distal long arm of chromosome 15 (q26. Iqter) and loss of insulin-like growth factor-1 receptor gene. American Journal of Medical Genetics, 38, 74-79.
31. Siebler, T., Lopaczynski, W., Terry, C.L., Casella, S.J., De Munson, P., Leon, D.D., Phang, L., Blakemore, K.J., McEvoy, R.C., Kelley, R.I. & Nissley, P. (1995) Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. Journal of Clinical Endocrinology and Metabolism, 80, 3447-3457.
32. Smith, W., Nam, T.J., Underwood, L.E., Busby, W.H., Celnicker, A. & Clemmons, D.R. (1993) Use of insulin-like growth factor-binding protein-2 (IGFBP-2), 1GFBP-3 and IGF-I for assessing growth hormone status in short children. Journal of Clinical Endocrinology and Metabolism, 77, 1294-1299.
33. Stannard, B., Blakesley, V.A., Kato, H., Roberts, C.T. Jr & LeRoith, D. (1995) Single tyrosine substitution in the insulin-like growth factor-I receptor inhibits biological activity and ligand-induced receptor internalization. Endocrinology, 136, 4918-4924.
34. Underwood,L.E. & Van Wyk, J.J. (1991) Normal and aberrant growth. In: Williams Textbook of Endocrinology 8th edn. (eds. J. Wilson & D. Foster), pp. 1079-1138. Saunders, Philadelphia.
35. Vaccarello, M.A., Diamond, F.B., Guevara-Aguirre, J.G., Rosenbloom, A.L., Fielder, P.J., Gargosky, S., Cohen, P., Wilson, K. & Rosenfeld, R.G. (1993) Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. Journal of Clinical Endocrinology and Metabolism, 77, 273-280.
36. Veldhuis, J.D., Carlson, M.L. & Johnson, M.L. (1987) The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proceedings of the National Academy of Sciences of the USA, 84, 7686-7690.
37. Vicini, L.J., Buonomo, F.C., Veenhuizen, J.J., Miller, M.A., Clemmons, D.R. & Collier, R.J. (1991) Effects of nutritional balance and stage of lactation in dairy cows on insulin, insulin-like growth factors I and II and insulin-like growth factor binding protein-2 responses to somatotropin administration. Journal of Nutrition, 121, 1656-1664.
38. Walker, J.L., Ginalska-Malinowska, M., Romer, T., Pucilowska, J.B. & Underwood, L.E. (1991) Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivily syndrome (Laron dwarfism). New England Journal of Medicine, 324, 1483-1488.
39. Woods, K.A., Hubner, C.C., Savage, M.O. & Clark, A.J.L. (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New England Journal of Medicine, 335, 1363-1367.
40. Zadik, Z., Landau, H., Chen, M., Altman, Y. & Lieherman, E. (1992) Assessment of growth hormone (GII) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation. Journal of Clinical Endocrinology and Metabolism, 75, 412-416.